Premium
WE‐C‐224C‐05: Tumor Brachytherapy Using Intratumoral Injection of Beta‐Emitting Therapeutic Radionuclides Carried Within Nanoparticles
Author(s) -
Bao A,
Phillips W,
Goins B,
Otto R
Publication year - 2006
Publication title -
medical physics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 180
eISSN - 2473-4209
pISSN - 0094-2405
DOI - 10.1118/1.2241710
Subject(s) - brachytherapy , nuclear medicine , liposome , gamma camera , radionuclide therapy , in vivo , spect imaging , biodistribution , medicine , chemistry , radiochemistry , biomedical engineering , materials science , radiation therapy , radiology , nanotechnology , microbiology and biotechnology , biology
The use of beta‐emitting therapeutic radionuclides carried within nanoparticles for brachytherapy potentially offers significantl advantages over sealed sources. By using an active trapping technique, both therapeutic radionuclides, 186 Re and 188 Re, and diagnostic radionuclides, 99m Tc, can be encapsulated in liposomes with high efficiency and high specific activity. 186 Re and 188 Re are beta emitters with appropriate ratio and energies of gamma emission which enable the imaging of in vivo distribution with a clinical gamma camera. The 90% absorbed dose deposit distances in soft tissue of beta ray from 186 Re and 188 Re are 1.8 mm and 4.2 mm respectively. To study the potential of using therapeutic radionuclides carried within liposomes for tumor brachytherapy, the intratumoral distribution and retention of 99m Tc‐liposomes in head and neck squamous cell carcinoma xenografts in nude rats were determined using imaging with a dedicated dual modality animal micro‐SPECT / CT scanner. Using an intratumoral administration technique developed in our lab, the volume of administered radioactivity up to over 40 % of tumor volume can be delivered to tumor with a high local retention. The 99m Tc‐liposome studies show that about 40 % of injected activity remained in tumor with a very slow clearance. The cleared activity was not retained in the nearby critical organ. Using pin‐hole collimators with a spatial resolution of 1 mm, the 99m Tc‐activity had a broad diffusion throughout the tumor even though the injection was at one point within the tumor. This study has shown the potential of using beta‐emitting therapeutic radionuclides carried within nanoparticles for tumor brachytherapy. The high intratumoral retention enables a high intratumoral radiation absorbed dose, while the penetration of beta‐particles within only a few mm decreases the toxicity to nearby critical organs, and the intratumoral diffusion makes the intratumoral administration simpler and provides for a better intratumoral absorbed dose homogeneity.